Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice

Diabetes

Volumn 53, Issue 1, 2004, Pages 82-90

  Blüher, Susann ^a   Ziotopoulou, Mary ^a   Bullen Jr , John W ^a   Moschos, Stergios J ^a   Ungsunan, Linda ^a   Kokkotou, Efi ^a   Maratos Flier, Eleftheria ^a   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; AGOUTI RELATED PROTEIN; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MELANOTETAN II; NEUROPEPTIDE Y; RECEPTOR; THYROXINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FOOD DEPRIVATION; FOOD INTAKE; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THYROXINE BLOOD LEVEL; WEIGHT REDUCTION;

ALPHA-MSH; ANIMALS; BODY WEIGHT; ENERGY INTAKE; GENE EXPRESSION REGULATION; LEPTIN; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, OBESE; NEUROPEPTIDE Y; RECEPTORS, CELL SURFACE; THINNESS; TIME FACTORS;

EID: 0346729967     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.1.82     Document Type: Article

References (38)

1. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484, 2001
2. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070, 1999
3. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141, 1997
4. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102, 2000
5. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168, 1997
6. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Bum P, Palmiter RD: Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21:119-122, 1999
7. Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA: Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am J Physiol Regul Integr Comp Physiol 278:R50-R59, 2000
8. Koegler FH, Grove KL, Schiffmacher A, Smith MS, Cameron JL: Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology 142:2586-2592, 2001
9. Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN: Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J Appl Physiol 89:273-282, 2000
10. Forbes S, Bui S, Robinson BR, Hochgeschwender U, Brennan MB: Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A 98:4233-4237, 2001
11. Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RA, Baskin DG, Schwartz MW, van Dijk G: Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 21:3639-3645, 2001
12. Satoh N, Ogawa Y, Katsuura G, Numuta Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249:107-110, 1998
13. Kask A, Schioth HB, Harro J, Wikberg JE, Rago L: Longitudinal administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. Neuroreport 10:707-711, 1999
14. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS: Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51:1337-1345, 2002
15. Mantzoros CS, Qu D, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E, Flier JS: Activation of β(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45:909-914, 1996
16. Lowell BB, Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-742, 1993
17. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS: Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279:E838-E845, 2000
18. Ziotopoulou M, Erani DM, Hileman SM, Bjorbaek C, Mantzoros CS: Unlike leptin, ciliary neurotrophic factor does not reverse the starvation induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes 49:1890-1896, 2000
19. Shinyama H, Masuzaki H, Fang H, Flier JS: Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144:1301-1314, 2003
20. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003
21. Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir LF, Schiöth HB: Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 12:3703-3708, 2001
22. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314, 1995
23. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832, 2000
24. Hamann A, Flier JS, Lowell BB: Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21-29, 1996
25. Mantzoros CS, Frederich RC, Qu D, Lowell BB, Maratos-Flier E, Flier JS: Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptideY and circulating corticosterone concentrations. Diabetes 47:230-238, 1998
26. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
27. Hwa JJ, Ghibaudi L, Gao J, Parker EM: Central melanocortin system modulated energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol 281:R444-R451, 2001
28. Cettour-Rose P, Rohner-Jeanrenaud F: The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143:2277-2283, 2002
29. Hansen MJ, Ball MJ, Morris MJ: Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892:130-137, 2001
30. McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW: Effect of intracerebroventricular alpha-MHS on food intake, adiposity, c-FOS induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 27:R695-R703, 2000
31. Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB: Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol 173:517-523, 2002
32. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, Watson SJ: Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in the brain. J Neurosci 19:RC26:1-7, 1999
33. Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G: Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res 674:112-116, 1995
34. Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T: A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol 274:R1500-R1504, 1998
35. Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD: Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res 848:66-77, 1999
36. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR: Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49:177-182, 2000
37. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD: The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141:3072-3079, 2000
38. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R: Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10:1095-1103, 2002